Literature DB >> 4044177

Comparison of I-123 IMP cerebral uptake and MR spectroscopy following experimental carotid occlusion.

B L Holman, F A Jolesz, J F Polak, J F Kronauge, D F Adams.   

Abstract

Both I-123 IMP scintigraphy and MRI have been suggested as sensitive detectors of changes shortly after acute cerebral infarction. We compared the uptake of N-isopropyl I-123 p-iodoamphetamine (IMP) and MR spectroscopy of the brain after internal carotid artery ligation. Thirteen gerbils were lightly anesthetized with ether. After neck dissection, an internal carotid artery was occluded. After 2.8 hours, 100 muCi I-123 IMP was injected intravenously into the 13 experimental animals plus three controls. Seven gerbils remained asymptomatic while six developed hemiparesis. At 3 hours after ligation, the animals were killed. The brains were bisected and T1 and T2 relaxation times were determined for the right and left hemispheres by MR spectroscopy immediately after dissection. I-123 IMP uptake was then determined in the samples. Interhemispheric differences in uptake for I-123 IMP were 0.1 +/- 1.7% (SEM) in the control, 33.5 +/- 10% in the asymptomatic and 54.6 +/- 9.7% in the symptomatic animals. Significant differences were seen with I-123 IMP in 6/7 asymptomatic and 6/6 symptomatic animals. In conclusion, I-123 is more sensitive than T1 or T2 relaxation times for the detection of cerebral perfusion abnormalities. Prolongation in T1 and T2 relaxation times correlates closely with increased brain tissue water content and the development of symptoms, indicators of structural brain damage and probable infarction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4044177     DOI: 10.1097/00004424-198507000-00006

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  1 in total

1.  The distribution of N-isopropyl-p-iodoamphetamine in temporary ischemic brain of the mongolian gerbil.

Authors:  S Jinnouchi; H Hoshi; K Watanabe; T Ueda; T Yamaguchi
Journal:  Eur J Nucl Med       Date:  1987
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.